Search research articles
Contact Us
Filters
Showing results (201-210 of 221) with videos related to
Page
of 23
Sort By:
Science (New York, N.Y.)
|
November 21, 1997
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
D Finzi, M Hermankova, T Pierson, et al.
Journal of Virology
|
December 16, 1998
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy
G S Ogg, X Jin, S Bonhoeffer, et al.
AIDS Research and Human Retroviruses
|
June 29, 2001
Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation
F Gao, N Vidal, Y Li, et al.
Science (New York, N.Y.)
|
April 16, 1998
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
G S Ogg, X Jin, S Bonhoeffer, et al.
Nature Medicine
|
November 1, 1996
The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
Y Huang, W A Paxton, S M Wolinsky, et al.
Nature Medicine
|
July 1, 1996
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
A Molla, M Korneyeva, Q Gao, et al.
The Journal of Experimental Medicine
|
September 8, 1999
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy
L Zhang, S R Lewin, M Markowitz, et al.
The Journal of Infectious Diseases
|
February 10, 1999
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses
M Markowitz, M Vesanen, K Tenner-Racz, et al.
The Journal of Clinical Investigation
|
September 24, 1999
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
G M Ortiz, D F Nixon, A Trkola, et al.
Journal of Virology
|
January 28, 1998
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines
R I Connor, B T Korber, B S Graham, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 221) with videos related to
Sort By:
Page
of 23
Science (New York, N.Y.)
|
November 21, 1997
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
D Finzi, M Hermankova, T Pierson, et al.
Journal of Virology
|
December 16, 1998
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy
G S Ogg, X Jin, S Bonhoeffer, et al.
AIDS Research and Human Retroviruses
|
June 29, 2001
Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation
F Gao, N Vidal, Y Li, et al.
Science (New York, N.Y.)
|
April 16, 1998
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
G S Ogg, X Jin, S Bonhoeffer, et al.
Nature Medicine
|
November 1, 1996
The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
Y Huang, W A Paxton, S M Wolinsky, et al.
Nature Medicine
|
July 1, 1996
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
A Molla, M Korneyeva, Q Gao, et al.
The Journal of Experimental Medicine
|
September 8, 1999
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy
L Zhang, S R Lewin, M Markowitz, et al.
The Journal of Infectious Diseases
|
February 10, 1999
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses
M Markowitz, M Vesanen, K Tenner-Racz, et al.
The Journal of Clinical Investigation
|
September 24, 1999
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
G M Ortiz, D F Nixon, A Trkola, et al.
Journal of Virology
|
January 28, 1998
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines
R I Connor, B T Korber, B S Graham, et al.
Page
of 23